They found that similar concentrations of GSE exerted a more profound effect in eradicating more advanced stages of colon cancer, indicating that the natural compound may provide an effective treatment option for more advanced forms of the disease. Ms. Derry noted “It required less than half the concentration of GSE to suppress cell growth and kill 50 percent of stage IV cells than it did to achieve similar results in the stage II cells.” The study team discovered that GSE targets colorectal cancer through inducing oxidative stress that leads to the programmed cell death known as apoptosis. Ms. Derry concluded “The many bioactive compounds of GSE are able to target multiple mutations. The more mutations a cancer presents, the more effective GSE is in targeting them.” Nutrition experts recommend supplementing with a standardized whole grape seed extract (150 to 250 mg) daily to provide a protective shield against colon and digestive cancers. Sources for this article include: http://www.sciencedaily.com/releases/2013/01/130117105843.htm About the author: John Phillip is a Certified Nutritional Consultant and Health Researcher and Author who writes regularly on the cutting edge use of diet, lifestyle modifications and targeted supplementation to enhance and improve the quality and length of life. John is the author of ‘Your Healthy Weight Loss Plan’, a comprehensive EBook explaining how to use Diet, Exercise, Mind and Targeted Supplementation to achieve your weight loss goal. Visit My Optimal Health Resource to continue reading the latest health news updates, and to download your copy of ‘Your Healthy Weight Loss Plan’. Stay informed! FREE subscription to the Health Ranger’s email newsletter Get breaking news alerts on GMOs, fluoride, superfoods, natural cures and more… Join over four million monthly readers. Email privacy 100% protected.
Phase III Colon Cancer Prevention Therapy Trial Now Open for Enrollment
In an earlier trial, people who had had adenomas removed from their colon who then took daily eflornithine and sulindac for three years lowered their risk of developing another adenoma during the following three years to less than one third of what it was for those who did not take the drugs. And they lowered their chances of developing a high-risk adenoma during that time by 90 percent. The PACES trial is being conducted under CPP’s IND, supported by the NCI, and primarily managed by SWOG. “This is a huge milestone for all of us today,” said Jeffrey Jacob, CEO of Cancer Prevention Pharmaceuticals. “We have worked collaboratively with the NCI, SWOG, and the US Food and Drug Administration (FDA) for over three years to get this pioneering trial up and running.” CPP has agreements in place with both SWOG and the NCI providing CPP exclusive access to the data from this trial for commercial and regulatory purposes. The Company is also considering supplementing this trial with a parallel study in Europe or Asia. Jacob said, “CPP was created to pave a regulatory pathway so that others in the industry would consider cancer risk-reduction therapythe prevention of cancer before it occursas a viable product development model that the Company believes holds the key to reducing death rates from cancer.” About Colon Adenoma Therapy (CAT) Polyps begin in the cells of glandular structures lining the colon. Most polyps are benign, but one kind is the cause of greater concernthe Colon Adenomatous Polyp (adenoma). This growth is associated with DNA changes in the lining of the colon. Up to 10% of these polyps can become cancerous within a 10 year period if undetected or ignored. For individuals with multiple polyps, the chance of at least one of these polyps becoming cancerous is very high. However, if malignant polyps are detected early, 90% of patients survive at least five years. Some individuals have a genetic tendency to develop polyps. Individuals age 50 or older have a higher risk of developing Colon Adenomatous Polyps. In addition to genetic factors, these polyps are associated with a diet high in fat and beef and low in fiber.
To Prevent Colon Cancer, Get Your Butt to the Doctor
And iffriends orloved ones resist the idea, Couric said to tell them to do it for the people who love and depend on them. Also, if your partner doesnt want to get screened, join them and suggest his and hers colonoscopies! she tweeted. Katie Couric Tweeted, “Get Your Butt to the Doctor!” Credit: Katie Couric. 3. Dont Die of Embarrassment There may be blood in stool, a change in bowel habits, diarrhea or a change in weight, experts from the NIH noted. Experts from Dana Farber added, A month or more narrowing of the stools, straining, change in stool shape are all symptoms of bowel problems. As many of our tweeters noted, people often ignore these symptoms or are too embarrassed to talk to the doctor about them. Here again, our chatters said to get over it. Get your butt to the doctor, Couric tweeted this comment was retweeted more than a dozen times. As Besser pointed out, however, other than polyps there may be no other symptoms in the early stages of the disease. Thats why its so important to have regular check-ups and get screened on a schedule set by you and your doctor. 4. Know the Risks Age is an important risk factor. Colon and rectal cancers most often strike people over the age of 50, but the disease can strike at any age. Although anyone can get colorectal cancer, its deadliest for minorities, because theyre less likely to get tested or seek treatment, the experts from the Colon Cancer Alliance said.